Literature DB >> 23468449

Saphenous vein graft perforation during percutaneous coronary intervention: a case series.

Konstantinos Marmagkiolis1, Emmanouil S Brilakis, Abdul Hakeem, Mehmet Cilingiroglu, Luc Bilodeau.   

Abstract

INTRODUCTION: The outcomes of perforation during aortocoronary saphenous vein graft (SVG) percutaneous coronary intervention (PCI) are poorly studied.
METHODS: We reviewed all 12 SVG perforations that occurred between November 2005 and November 2011 at two tertiary referral centers. The acute and long-term outcomes of these patients were examined.
RESULTS: The perforation was located in the SVG body (n = 6), aortic (n = 3), or distal (n = 3) anastomosis. Most perforations occurred after stent implantation (n = 5) or after stent postdilation (n = 3). The perforation was Ellis class I in 1 patient, II in 3 patients, III in 4 patients, and III with cavity spilling in 3 patients. The perforation spontaneously sealed without requiring further treatment in 3 patients. In the remaining 9 patients, the perforation was treated with prolonged balloon inflation (n = 2) or covered stent implantation (n = 5), but could not be treated in 2 patients who died during the procedure. Seven of the 10 survivors underwent follow-up angiography 5 months to 2 years after the perforation. The target SVG was occluded in 5 patients and had developed severe stenosis in the remaining 2 patients.
CONCLUSIONS: SVG perforation during PCI carries a high mortality and frequently requires implantation of a covered stent. Perforated SVGs frequently occlude within 2 years post PCI.

Entities:  

Mesh:

Year:  2013        PMID: 23468449

Source DB:  PubMed          Journal:  J Invasive Cardiol        ISSN: 1042-3931            Impact factor:   2.022


  7 in total

1.  Saphenous Vein Graft Perforation During Percutaneous Coronary Intervention - A Nightmare to be Avoided.

Authors:  Surender Deora; Sanjay C Shah; Tejas M Patel
Journal:  Heart Views       Date:  2015 Jan-Mar

2.  Percutaneous coronary intervention for distal coronary graft anastomosis le-sions: a case series.

Authors:  A Tassopoulos; M Didagelos; I Tsiafoutis; A Ziakas; M Koutouzis
Journal:  Hippokratia       Date:  2019 Apr-Jun       Impact factor: 0.471

3.  Outcomes With the Use of the Retrograde Approach for Coronary Chronic Total Occlusion Interventions in a Contemporary Multicenter US Registry.

Authors:  Dimitri Karmpaliotis; Aris Karatasakis; Khaldoon Alaswad; Farouc A Jaffer; Robert W Yeh; R Michael Wyman; William L Lombardi; J Aaron Grantham; David E Kandzari; Nicholas J Lembo; Anthony Doing; Mitul Patel; John N Bahadorani; Jeffrey W Moses; Ajay J Kirtane; Manish Parikh; Ziad A Ali; Sanjog Kalra; Phuong-Khanh J Nguyen-Trong; Barbara A Danek; Judit Karacsonyi; Bavana V Rangan; Michele K Roesle; Craig A Thompson; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Circ Cardiovasc Interv       Date:  2016-06       Impact factor: 6.546

4.  [Not Available].

Authors:  Chiu-Fen Yang; Michael Y Chen; Mei-Ling Chen; Ji-Hung Wang
Journal:  Acta Cardiol Sin       Date:  2014-09       Impact factor: 2.672

5.  Saphenous vein graft interventions.

Authors:  Emmanouil S Brilakis; Michael Lee; Julinda Mehilli; Konstantinos Marmagkiolis; Josep Rodes-Cabau; Rajesh Sachdeva; Anna Kotsia; George Christopoulos; Bavana V Rangan; Atif Mohammed; Subhash Banerjee
Journal:  Curr Treat Options Cardiovasc Med       Date:  2014-05

6.  Clinical Outcomes of Polytetrafluoroethylene-Covered Stents for Coronary Artery Perforation in Elderly Patients Undergoing Percutaneous Coronary Interventions.

Authors:  Huang-Joe Wang; Jen-Jyh Lin; Wan-Yu Lo; Chih-Ping Chang; Chung-Ho Hsu; Li-Chuan Hsieh; Yeh-Peng Chen; Yen-Nien Lin; Kuan-Cheng Chang; Ping-Han Lo
Journal:  Acta Cardiol Sin       Date:  2017-11       Impact factor: 2.672

Review 7.  Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Prior Coronary Artery Bypass Graft: Current Evidence and Future Perspectives.

Authors:  Lei Guo; Haichen Lv; Xiaomeng Yin
Journal:  Front Cardiovasc Med       Date:  2022-04-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.